Optimizing Movement Disorder Clinical Trials: A Focus On Parkinson's Disease

Advancing new therapies for Parkinson's disease requires carefully designed clinical trials that address the unique scientific, regulatory, and operational challenges of neurologic drug development. As symptomatic and disease-modifying treatments continue to evolve, sponsors must adapt and navigate trial designs, endpoint selection, and development strategies to move programs forward efficiently.

In this webinar, experts from Dr. Vince Clinical Research (DVCR) discuss the latest developments shaping Parkinson's disease clinical research. The session will examine key considerations across symptomatic and disease-modifying study designs, with a focus on patient-centered research and successful trial execution.